Condition: Heart Failure With Preserved Ejection Fraction · Hypertension, Renal · Sponsor: University of Leipzig
Heart failure with preserved ejection fraction has a high mortality, which is contrasted by a total absence of therapy options besides symptomatic diuretic treatment. This study aims to explore the potential of renal denervation as a treatment option for heart failure with preserved ejection fraction.
This description comes directly from the study's public registry record.
Karl Fengler, PhD · 49 341 · Karl.Fengler@medizin.uni-leipzig.de
Philipp Lurz, Prof. Dr. · 49 6131 · lurzphil@uni-mainz.de
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Halle (Saale), Klinik und Poliklinik für Innere Medizin III | Halle, Saxony-Anhalt, Germany | Recruiting |
| BG Klinikum Unfallkrankenhaus Berlin gGmbH | Berlin, Germany | Recruiting |
| Universitätsklinikum Leipzig, Klinik und Poliklinik für Kardiologie | Leipzig, Germany | Not Yet Recruiting |
| Herzzentrum Leipzig, Universitätsklinik für Kardiologie | Leipzig, Germany | Recruiting |
| Universitätsmedizin der Johannes Gutenberg Universität Mainz, Zentrum für Kardiologie / Kardiologie 1 | Mainz, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05030987